NCT00327145

A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy

A Double-blind, Randomized, Multicenter Study to Evaluate the Effectiveness of the Combination of Valsartan & Amlodipine in Hypertensive Patients Not Controlled on Monotherapy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 894 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

This study is designed to provide additional efficacy and safety data for a treatment strategy based on the combination valsartan with amlodipine in hypertensive patients previously treated with monotherapy and remaining uncontrolled. A naturalistic approach will be taken comparing two different doses, i.e. 160mg of valsartan with amlodipine 5mg and 10mg with possible addition of HCTZ

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	valsartan
DRUG	hydrochlorothiazide
DRUG	amlodipine

Timeline

• Start date: 2006-03-01
• Primary completion: 2007-01-01
• Completion: 2007-01-01
• First posted: 2006-05-18
• Last updated: 2016-11-18

Locations

1 site across 1 country: Switzerland